North Coast Angel Fund
-
Angel groups are investing more but making the money harder to get
This is the second of a two-part series on the evolution of angel investing. To […]
-
An entrepreneur’s quick guide to working with angel investors
The number of angel investors in the U.S. has jumped 60 percent since 2002, […]
-
Streamline the Process for Consent Collection and Management
Join us on April 16th and hear executives from DocuSign and Velatura discuss how their partnership modernizes and facilitates the efficient and secure completion of the patient consent form.
-
Great Lakes Pharmaceuticals turns to Europe for first clinical trial of catheter lock solution
A Cleveland company developing catheter infection prevention technology has reached a big milestone in the […]
-
North Coast Angels near $8M close for second fund
Northeast Ohio’s largest angel investor group, North Coast Angel Fund, is nearing an $8 million close on its second fund.
-
North Coast Angel Fund back in fundraising mode
Early stage investment group North Coast Angel Fund is raising money for a second fund, having pulled in commitments for $800,000. In all likelihood, North Coast Angels are looking to raise $8 million for the group’s second fund.
-
Peripheral artery disease drug developer TheraVasc raises $1.8M
TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised a $1.8 million Series A1 round of investment capital. But the company isn’t stopping there — it’s looking to add about $450,000 to the round.
-
Columbus venture group Ohio TechAngel Funds raises $2.5M for third fund
Early stage venture group Ohio TechAngel Funds has raised $2.5 million for its third investment fund. Like the group’s previous funds, Ohio TechAngel Fund III will invest in Ohio-based technology companies in the life and physical sciences, and information technology industries.
-
Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors
Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.
-
CerviLenz closes on $4 million Series A round to create preterm pregnancy detector
The company is developing a disposable device that measures the length of a woman’s cervix to help predict risks of preterm birth. It is potentially easier, less costly and just as accurate as the transvaginal ultrasound device used in only high-risk pregnancies. It could be in the market by 2010.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.